Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Lteif: Endothelin limits insulin action in obese/insulin-resistant humans. (0.10 sec) 

Endothelin limits insulin action in obese/insulin-resistant humans


A Lteif, P Vaishnava, AD Baron, KJ Mather - Diabetes, 2007 - Am Diabetes Assoc
The normal action of insulin to vasodilate and redistribute blood flow in support of skeletal muscle
metabolism is impaired in insulin-resistant states. Increased endogenous endothelin contributes
to endothelial dysfunction in obesity and diabetes. Here, we test the hypothesis that ...
Cited by 24 - Related articles - BL Direct - All 6 versions

Dual endothelin receptor blockade acutely improves insulin sensitivity in obese …

- diabetesjournals.org
G Ahlborg, A Shemyakin, F Böhm, A Gonon, J … - Diabetes care, 2007 - Am Diabetes Assoc
RESULTS—Total-body glucose uptake (M) differed between the clamp protocols with the highest
value in the BQ123+BQ788 clamp (P < 0.05). The M value corrected by insulin was higher in
the BQ123+BQ788 than in the control clamp (P < 0.01) or the BQ123 clamp (P < 0.05). ...
Cited by 11 - Related articles - BL Direct - All 7 versions

Acute blockade by endothelin-1 of haemodynamic insulin action in rats

- pubget.com [PDF] 
RM Ross, CM Kolka, S Rattigan, MG Clark - Diabetologia, 2007 - Springer
Abstract Aims/hypothesis Plasma levels of endothelin-1 are fre- quently elevated in patients with
hypertension, obesity and type 2 diabetes. We hypothesise that this vasoconstric- tor may prevent
full perfusion of muscle, thereby limiting delivery of insulin and glucose and contributing ...
Cited by 10 - Related articles - BL Direct - All 7 versions

Insulin sensitivity and big ET-1 conversion to ET-1 after ETA-or ETB-receptor …

- physiology.org
G Ahlborg, J Lindstrom - Journal of Applied Physiology, 2002 - Am Physiological Soc
Cardiovascular diseases are characterized by insulin resistance and elevated endothelin
(ET)-1 levels. Furthermore, ET-1 induces insulin resistance. To elucidate this mechanism, six
healthy subjects were studied during a hyperinsulinemic euglycemic clamp during ...
Cited by 14 - Related articles - BL Direct - All 6 versions

Effect of bosentan (ETA/ETB receptor antagonist) on metabolic changes during …


SA Said, ESM Ammar, GM Suddek - Pharmacological Research, 2005 - Elsevier
Elevated plasma ET-1 levels have been reported in several conditions such as stress and
diabetes. ET-1 is found to cause insulin resistance and to stimulate liver glycogenolysis. The
question arises whether ET-1 has a role in the metabolic changes occurring in such ...
Cited by 6 - Related articles - All 3 versions

Metabolic responses with endothelin antagonism in a model of insulin resistance


N Berthiaume, JL Wessale, TJ Opgenorth, BA Zinker - Metabolism, 2005 - Elsevier
Atrasentan, an endothelin antagonist, would have beneficial effects on metabolic responses
in a model of insulin resistance. Zucker lean or fatty rats were maintained either on regular (lean
and fatty control, n = 12) or atrasentan-treated water (5 mg/kg/d, fatty atrasentan, n = 13) ...
Cited by 7 - Related articles - All 12 versions

Protein Kinase C θ Activation Induces Insulin-Mediated Constriction of Muscle …


W Bakker, P Sipkema, CDA Stehouwer, EH Serne, YM … - Diabetes, 2008 - Am Diabetes Assoc
RESULTS—In the absence of PKC activation, insulin did not alter arterial diameter, which was
caused by a balance of nitric oxide–dependent vasodilator and endothelin-dependent vasoconstrictor
effects. Using three-dimensional microscopy and Western blotting of muscle resistance ...
Cited by 8 - Related articles - BL Direct - All 4 versions

Weight loss reduces plasma endothelin-1 concentration in obese men

- ebmonline.org
S Maeda, S Jesmin, M Iemitsu, T Otsuki, T Matsuo, K … - Experimental Biology and …, 2006 - SEBM
Obesity is associated with endothelial dysfunction that may contribute to the development of
diabetes, hypertension, and atherosclerosis. Endothelin-1 (ET-1), which is produced mostly by
vascular endothelial cells, has potent vasoconstrictor and proliferative activity in vascular ...
Cited by 10 - Related articles - BL Direct - All 3 versions

Endothelin A-receptor blockade in experimental diabetes improves glucose …


B Balsiger, A Rickenbacher, PJ Boden, E … - Clinical …, 2002 - cs.portlandpress.com
Secondary complications of diabetes mellitus often involve gastrointestinal dysfunction. In the
experimental Goto Kakizaki rat, a model of Type II diabetes, hyperglycaemia and reduced glucose
clearance is associated with elevated plasma endothelin (ET)-1 levels and selective ...
Cited by 13 - Related articles - Cached - BL Direct - All 13 versions

Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed …


AA Lteif, AD Fulford, RV Considine, I … - American Journal of …, 2008 - Am Physiological Soc
Endogenous endothelin action is augmented in human obesity and type 2 diabetes and contributes
to endothelial dysfunction and impairs insulin-mediated vasodilation in humans. We hypothesized
that insulin resistance-associated hyperinsulinemia could preferentially drive endothelin- ...
Cited by 2 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google